GLPwatch
Bydureon vs Soliqua
Drug comparison
Last updated 2026-05-28 15:46 UTCBydureon and Soliqua are both injectable medications for type 2 diabetes. Bydureon uses the active ingredient exenatide, while Soliqua uses lixisenatide. Both are given as shots under the skin, but Bydureon is made by AstraZeneca and Soliqua is made by Sanofi.
AI summary of the sources below.
| Bydureon | Soliqua | |
|---|---|---|
| Active ingredient | exenatide | lixisenatide |
| Manufacturer | astrazeneca | sanofi |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | — | 2026-03-18 |